Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from TQ-A3334 and Anlotinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets clinical trial (NCT06507891). Contact the study team or your healthcare provider for specific answers.

What this study is about